bemcentinib (BGB324)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for bemcentinib (BGB324), covering 2025-01-29 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]